Conclusionthe developedsyntheticmediumandpurificationprocedure were feasible and provided an experimentalbasisfor the preparation of tetravalent meningococcuspolysaccharidevaccine.
There are vaccines for other meningococcus strains, but a vaccine for the group B strains had been eluding microbiologists because their surface sugars are identical to human ones.